Simplex Trading’s ProShares Ultra CRCL CRCA Stock Holding History

Simplex Trading’s Portfolio CRCA Stock Details CRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.8K	Sell	609 -4,256	-87%	-$164K	﹤0.01%	7880
2026 Q1	$201K	Buy	4,865 +4,433	+1,026%	+$184K	﹤0.01%	4292
2025 Q4	$17.5K	Sell	432 -441	-51%	-$37.8K	﹤0.01%	6599
2025 Q3	$127K	Buy	+873	New	+$141K	﹤0.01%	5483

Other funds holding CRCA

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading's CRCA Position: Q2 2026 in Review

Simplex Trading reduced its ProShares Ultra CRCL (CRCA) stake by 87% in Q2 2026, selling an estimated $164K and leaving 609 shares worth $7.8K. The position accounts for ﹤0.01% of the portfolio, ranked #7880.

Simplex Trading first reported a position in CRCA in Q3 2025 and has held it in 4 quarters since. The position peaked at $201K in Q1 2026. 7 funds tracked by Wall St. Rank hold CRCA as of Q2 2026.

Simplex Trading held 609 shares of ProShares Ultra CRCL worth $7.8K as of Q2 2026.
Simplex Trading sold 4,256 ProShares Ultra CRCL shares in Q2 2026, an estimated $164K.
ProShares Ultra CRCL made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7880 holding.
Simplex Trading first reported a position in ProShares Ultra CRCL in Q3 2025 and has held it in 4 quarters since.
Simplex Trading's ProShares Ultra CRCL position peaked at $201K in Q1 2026.
7 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.